Skip to main navigation
  • Investor Home
  • News & Presentations
    News Events Presentations
  • Governance
    Governance Overview Board of Directors Leadership Our ESG Philosophy
  • Financials
    SEC Filings Quarterly Results Annual Reports
  • Stock Information
    Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
  • Resources
    Pipeline Investor FAQs Email Alerts Contact IR

News Releases


Jan 14, 2023

Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of

Read More

Jan 05, 2023

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More
Print Page
RSS Feeds
Email Alerts
Search
Arcutis Biotherapeutics logo
  • Contact

 (805) 418-5006
 emcintyre@arcutis.com

  • Legal Disclaimer
  • Privacy Notice
  • Cookie Settings

Social Links

  • LinkedIn
  • Twitter
© 2023 Arcutis Biotherapeutics